Atomoxetine, sold under the brand name Strattera, is a nonstimulant medication used to treat ADHD. It can be helpful for people who cannot take stimulants or who prefer a medication with less misuse potential. However, it is not the right fit for everyone. Some people experience limited improvement, stomach upset, sleep changes, mood-related effects, or a slower response than they expected.
When atomoxetine is ineffective or poorly tolerated, a prescriber may consider another nonstimulant, a stimulant medication, or a treatment plan that combines medication with behavioral and practical support. The best alternative depends on the person’s age, symptoms, medical history, other medications, previous treatment response, and priorities.
Why consider an alternative to Strattera?
People may look for a different ADHD treatment for several reasons:
- Attention, impulsivity, or hyperactivity symptoms remain disruptive.
- Side effects such as nausea, appetite changes, sleep disruption, fatigue, or mood changes are difficult to manage.
- The medication’s gradual onset does not meet the person’s need for symptom relief.
- Other health conditions, medications, pregnancy considerations, or substance-use concerns affect the choice.
- Cost, availability, or insurance coverage makes another option more practical.
A medication change should be planned with the prescribing clinician. The prescriber can assess whether the dose and timing are appropriate, whether another condition is affecting symptoms, and whether switching or adjusting treatment makes sense.
Nonstimulant alternatives
Guanfacine and clonidine
Extended-release guanfacine and extended-release clonidine are nonstimulant options that may be considered, particularly when hyperactivity, impulsivity, or sleep difficulties are prominent. They can cause tiredness, sedation, dizziness, or low blood pressure in some people. If guanfacine is not effective or causes excessive daytime sleepiness, clonidine may be considered, although the two medications are not interchangeable without medical guidance.
Viloxazine
Viloxazine extended release is another nonstimulant option for ADHD. It may be considered when a person wants to avoid stimulants or has not benefited from atomoxetine. Its effects and tolerability can differ from those of other nonstimulants, so follow-up is important when starting or adjusting it.
Bupropion
Bupropion is an antidepressant that may be used off label for ADHD. It can be a consideration when ADHD occurs alongside depressive symptoms, but it is not appropriate for everyone. A clinician must review medical history, other medications, and individual risks before prescribing it for ADHD.
Stimulant options after atomoxetine
Stimulants, including methylphenidate and amphetamine-based medications, are another category clinicians may discuss when atomoxetine has not provided enough benefit. They often work more quickly than nonstimulants and may offer stronger improvement in core ADHD symptoms for some people.
Potential concerns include reduced appetite, sleep problems, increased heart rate or blood pressure, and misuse risk. Long-acting formulations, careful dosing, and regular monitoring may help address some concerns. Lisdexamfetamine may also be discussed when a clinician wants an amphetamine formulation with lower immediate abuse potential than some other stimulant preparations. Whether it is suitable depends on the person’s health history and treatment goals.
A cardiovascular review and ongoing monitoring are especially important when stimulant treatment is being considered. People should tell their prescriber about heart-related symptoms, high blood pressure, substance-use history, and all other medications they take.
Finding an ADHD medication with fewer side effects
There is no single ADHD medication that has the fewest side effects for everyone. The most tolerable choice depends on which adverse effects are most concerning for a particular person. For example, someone troubled by fatigue may prefer to avoid medications that commonly cause sedation, while someone with a history of substance misuse may place greater emphasis on nonstimulant options.
Clinicians often begin with a low dose and adjust it gradually while tracking both symptom improvement and unwanted effects. Follow-up may include discussion of:
- Attention, impulsivity, hyperactivity, and daily functioning
- Appetite, weight, and sleep
- Mood, anxiety, and irritability
- Heart rate and blood pressure
- School, work, driving, and relationship functioning
Medication is only part of the treatment plan
Medication changes are often more effective when paired with practical support. Cognitive behavioral therapy, organizational coaching, sleep routines, classroom accommodations, and strategies for managing time and tasks can help address the functional effects of ADHD. These approaches may be particularly important when medication benefits are limited or side effects prevent continued use.
Choosing a Strattera alternative is a collaborative process rather than a search for one universally best drug. Discuss the desired benefits, acceptable tradeoffs, health conditions, and monitoring plan with a qualified prescriber before starting, stopping, or changing ADHD medication.
Dr. Jonathon Preston is a respected mental health specialist dedicated to helping individuals overcome challenges. With advanced training in psychology and decades of experience in the mental health field.